John Kurhanewicz - Publications

Affiliations: 
Bioengineering University of California, San Francisco, San Francisco, CA 
Area:
Biomedical, Biochemistry

300 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Starobinets O, Simko JP, Gibbons M, Kurhanewicz J, Carroll PR, Noworolski SM. The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRI. Magnetic Resonance Imaging. 110233. PMID 39260625 DOI: 10.1016/j.mri.2024.110233  0.331
2023 Mu C, Liu X, Kim Y, Riselli A, Korenchan DE, Bok RA, Delos Santos R, Sriram R, Qin H, Nguyen H, Gordon JW, Slater J, Larson PEZ, Vigneron DB, Kurhanewicz J, et al. Clinically Translatable Hyperpolarized C Bicarbonate pH Imaging Method for Use in Prostate Cancer. Acs Sensors. PMID 37878761 DOI: 10.1021/acssensors.3c00851  0.339
2023 Sahin SI, Ji X, Agarwal S, Sinha A, Mali I, Gordon JW, Mattingly M, Subramaniam S, Kurhanewicz J, Larson PEZ, Sriram R. Metabolite-Specific Echo Planar Imaging for Preclinical Studies with Hyperpolarized C-Pyruvate MRI. Tomography (Ann Arbor, Mich.). 9: 736-749. PMID 37104130 DOI: 10.3390/tomography9020059  0.338
2022 Agudelo JP, Upadhyay D, Zhang D, Zhao H, Nolley R, Sun J, Agarwal S, Bok RA, Vigneron DB, Brooks JD, Kurhanewicz J, Peehl DM, Sriram R. Multiparametric Magnetic Resonance Imaging and Metabolic Characterization of Patient-Derived Xenograft Models of Clear Cell Renal Cell Carcinoma. Metabolites. 12. PMID 36422257 DOI: 10.3390/metabo12111117  0.34
2022 Chen HY, Bok RA, Cooperberg MR, Nguyen HG, Shinohara K, Westphalen AC, Wang ZJ, Ohliger MA, Gebrezgiabhier D, Carvajal L, Gordon JW, Larson PEZ, Aggarwal R, Kurhanewicz J, Vigneron DB. Improving Multiparametric MR-Transrectal ultrasound Guided Fusion Prostate biopsies with Hyperpolarized C Pyruvate Metabolic imaging: A technical development study. Magnetic Resonance in Medicine. PMID 35975978 DOI: 10.1002/mrm.29399  0.391
2022 Liu X, Tang S, Mu C, Qin H, Cui D, Lai YC, Riselli AM, Delos Santos R, Carvajal L, Gebrezgiabhier D, Bok RA, Chen HY, Flavell RR, Gordon JW, Vigneron DB, ... Kurhanewicz J, et al. Development of specialized magnetic resonance acquisition techniques for human hyperpolarized [ C, N ]urea + [1- C]pyruvate simultaneous perfusion and metabolic imaging. Magnetic Resonance in Medicine. PMID 35526263 DOI: 10.1002/mrm.29266  0.327
2021 de Kouchkovsky I, Chen HY, Ohliger MA, Wang ZJ, Bok RA, Gordon JW, Larson PEZ, Frost M, Okamoto K, Cooperberg MR, Kurhanewicz J, Vigneron DB, Aggarwal R. Hyperpolarized 1-[C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer. European Urology. PMID 34758912 DOI: 10.1016/j.eururo.2021.10.015  0.379
2021 Gibbons M, Starobinets O, Simko JP, Kurhanewicz J, Carroll PR, Noworolski SM. Identification of prostate cancer using multiparametric MR imaging characteristics of prostate tissues referenced to whole mount histopathology. Magnetic Resonance Imaging. PMID 34666162 DOI: 10.1016/j.mri.2021.10.008  0.364
2021 Qin H, Tang S, Riselli AM, Bok RA, Delos Santos R, van Criekinge M, Gordon JW, Aggarwal R, Chen R, Goddard G, Zhang CT, Chen A, Reed G, Ruscitto DM, Slater J, ... ... Kurhanewicz J, et al. Clinical translation of hyperpolarized C pyruvate and urea MRI for simultaneous metabolic and perfusion imaging. Magnetic Resonance in Medicine. PMID 34374471 DOI: 10.1002/mrm.28965  0.341
2021 Sun J, Bok RA, DeLos Santos J, Upadhyay D, DeLos Santos R, Agarwal S, Van Criekinge M, Vigneron DB, Aggarwal R, Peehl DM, Kurhanewicz J, Sriram R. Resistance to Androgen Deprivation Leads to Altered Metabolism in Human and Murine Prostate Cancer Cell and Tumor Models. Metabolites. 11. PMID 33652703 DOI: 10.3390/metabo11030139  0.404
2020 Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, Feng FY, Reiter RE, Rettig MB, Nickols NG, Kishan AU, Slavik R, Carroll PR, Lawhn-Heath C, et al. False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32808077 DOI: 10.1007/S00259-020-04945-1  0.317
2020 Chen HY, Autry AW, Brender JR, Kishimoto S, Krishna MC, Vareth M, Bok RA, Reed GD, Carvajal L, Gordon JW, van Criekinge M, Korenchan DE, Chen AP, Xu D, Li Y, ... ... Kurhanewicz J, et al. Tensor image enhancement and optimal multichannel receiver combination analyses for human hyperpolarized C MRSI. Magnetic Resonance in Medicine. PMID 32501614 DOI: 10.1002/Mrm.28328  0.397
2020 Qin H, Zhang V, Bok RA, Santos RD, Cunha JA, Hsu IC, Santos JD, Lee JE, Sukumar S, Larson PEZ, Vigneron DB, Wilson DM, Sriram R, Kurhanewicz J. Simultaneous metabolic and perfusion imaging using hyperpolarized C MRI can evaluate early and dose-dependent responses to radiotherapy in a prostate cancer mouse model. International Journal of Radiation Oncology, Biology, Physics. PMID 32339646 DOI: 10.1016/J.Ijrobp.2020.04.022  0.772
2020 Crane JC, Gordon JW, Chen HY, Autry AW, Li Y, Olson MP, Kurhanewicz J, Vigneron DB, Larson PEZ, Xu D. Hyperpolarized C MRI data acquisition and analysis in prostate and brain at University of California, San Francisco. Nmr in Biomedicine. e4280. PMID 32189442 DOI: 10.1002/Nbm.4280  0.456
2020 Sriram R, Van Criekinge M, DeLos Santos J, Ahamed F, Qin H, Nolley R, Santos RD, Tabatabai ZL, Bok RA, Keshari KR, Vigneron DB, Peehl DM, Kurhanewicz J. Elevated Tumor Lactate and Efflux in High-grade Prostate Cancer demonstrated by Hyperpolarized C Magnetic Resonance Spectroscopy of Prostate Tissue Slice Cultures. Cancers. 12. PMID 32110965 DOI: 10.3390/Cancers12030537  0.514
2019 Korenchan DE, Bok R, Sriram R, Liu K, Santos RD, Qin H, Lobach I, Korn N, Wilson DM, Kurhanewicz J, Flavell RR. Hyperpolarized pH imaging reveals grade-dependent acidification in prostate cancer. Oncotarget. 10: 6096-6110. PMID 31692908 DOI: 10.18632/Oncotarget.27225  0.455
2019 Chen HY, Aggarwal R, Bok RA, Ohliger MA, Zhu Z, Lee P, Gordon JW, van Criekinge M, Carvajal L, Slater JB, Larson PEZ, Small EJ, Kurhanewicz J, Vigneron DB. Hyperpolarized C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study. Prostate Cancer and Prostatic Diseases. PMID 31685983 DOI: 10.1038/S41391-019-0180-Z  0.516
2019 Chung BT, Chen HY, Gordon J, Mammoli D, Sriram R, Autry AW, Le Page LM, Chaumeil M, Shin P, Slater J, Tan CT, Suszczynski C, Chang S, Li Y, Bok RA, ... ... Kurhanewicz J, et al. First hyperpolarized [2-C]pyruvate MR studies of human brain metabolism. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 309: 106617. PMID 31648132 DOI: 10.1016/J.Jmr.2019.106617  0.393
2019 Wang S, Korenchan DE, Perez PM, Taglang C, Hayes TR, Sriram R, Bok R, Hong AS, Wu Y, Li H, Wang Z, Kurhanewicz J, Wilson D, Flavell R. Amino Acid-Derived Sensors For Specific Zn2+ Detection Using Hyperpolarized 13C Magnetic Resonance Spectroscopy. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 31338914 DOI: 10.1002/Chem.201902771  0.409
2019 Barskiy DA, Tayler MCD, Marco-Rius I, Kurhanewicz J, Vigneron DB, Cikrikci S, Aydogdu A, Reh M, Pravdivtsev AN, Hövener JB, Blanchard JW, Wu T, Budker D, Pines A. Zero-field nuclear magnetic resonance of chemically exchanging systems. Nature Communications. 10: 3002. PMID 31278303 DOI: 10.1038/S41467-019-10787-9  0.316
2019 Korenchan DE, Gordon JW, Subramaniam S, Sriram R, Baligand C, VanCriekinge M, Bok R, Vigneron DB, Wilson DM, Larson PEZ, Kurhanewicz J, Flavell RR. Using bidirectional chemical exchange for improved hyperpolarized [ C]bicarbonate pH imaging. Magnetic Resonance in Medicine. PMID 31050049 DOI: 10.1002/Mrm.27780  0.321
2019 Bancroft Brown J, Sriram R, VanCriekinge M, Delos Santos R, Sun J, Delos Santos J, Tabatabai ZL, Shinohara K, Nguyen H, Peehl DM, Kurhanewicz J. NMR quantification of lactate production and efflux and glutamate fractional enrichment in living human prostate biopsies cultured with [1,6- C ]glucose. Magnetic Resonance in Medicine. PMID 30924180 DOI: 10.1002/Mrm.27739  0.464
2019 Zhu Z, Zhu X, Ohliger MA, Tang S, Cao P, Carvajal L, Autry AW, Li Y, Kurhanewicz J, Chang S, Aggarwal R, Munster P, Xu D, Larson PEZ, Vigneron DB, et al. Coil combination methods for multi-channel hyperpolarized C imaging data from human studies. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 301: 73-79. PMID 30851668 DOI: 10.1016/J.Jmr.2019.01.015  0.31
2019 Wang ZJ, Ohliger MA, Larson PEZ, Gordon JW, Bok RA, Slater J, Villanueva-Meyer JE, Hess CP, Kurhanewicz J, Vigneron DB. Hyperpolarized C MRI: State of the Art and Future Directions. Radiology. 182391. PMID 30835184 DOI: 10.1148/Radiol.2019182391  0.408
2019 Bok R, Lee J, Sriram R, Keshari K, Sukumar S, Daneshmandi S, Korenchan DE, Flavell RR, Vigneron DB, Kurhanewicz J, Seth P. The Role of Lactate Metabolism in Prostate Cancer Progression and Metastases Revealed by Dual-Agent Hyperpolarized C MRSI. Cancers. 11. PMID 30813322 DOI: 10.3390/Cancers11020257  0.5
2019 Chen HY, Gordon JW, Bok RA, Cao P, von Morze C, van Criekinge M, Milshteyn E, Carvajal L, Hurd RE, Kurhanewicz J, Vigneron DB, Larson PEZ. Pulse sequence considerations for quantification of pyruvate-to-lactate conversion k in hyperpolarized C imaging. Nmr in Biomedicine. e4052. PMID 30664305 DOI: 10.1002/Nbm.4052  0.303
2018 Kurhanewicz J, Vigneron DB, Ardenkjaer-Larsen JH, Bankson JA, Brindle K, Cunningham CH, Gallagher FA, Keshari KR, Kjaer A, Laustsen C, Mankoff DA, Merritt ME, Nelson SJ, Pauly JM, Lee P, et al. Hyperpolarized C MRI: Path to Clinical Translation in Oncology. Neoplasia (New York, N.Y.). 21: 1-16. PMID 30472500 DOI: 10.1016/J.Neo.2018.09.006  0.466
2018 Behr SC, Aggarwal R, Van Brocklin HF, Flavell RR, Geo K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, et al. First-in-Human Phase I study of CTT1057, a Novel F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30464040 DOI: 10.2967/Jnumed.118.220715  0.44
2018 Gordon JW, Chen HY, Autry A, Park I, Van Criekinge M, Mammoli D, Milshteyn E, Bok R, Xu D, Li Y, Aggarwal R, Chang S, Slater JB, Ferrone M, Nelson S, ... Kurhanewicz J, et al. Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients. Magnetic Resonance in Medicine. PMID 30375043 DOI: 10.1002/Mrm.27549  0.448
2018 Zhu X, Gordon JW, Bok RA, Kurhanewicz J, Larson PEZ. Dynamic diffusion-weighted hyperpolarized C imaging based on a slice-selective double spin echo sequence for measurements of cellular transport. Magnetic Resonance in Medicine. PMID 30368893 DOI: 10.1002/Mrm.27501  0.355
2018 Larson PEZ, Chen HY, Gordon JW, Korn N, Maidens J, Arcak M, Tang S, Criekinge M, Carvajal L, Mammoli D, Bok R, Aggarwal R, Ferrone M, Slater JB, Nelson SJ, ... Kurhanewicz J, et al. Investigation of analysis methods for hyperpolarized 13C-pyruvate metabolic MRI in prostate cancer patients. Nmr in Biomedicine. e3997. PMID 30230646 DOI: 10.1002/Nbm.3997  0.467
2018 Sriram R, Gordon J, Baligand C, Ahamed F, Delos Santos J, Qin H, Bok RA, Vigneron DB, Kurhanewicz J, Larson PEZ, Wang ZJ. Non-Invasive Assessment of Lactate Production and Compartmentalization in Renal Cell Carcinomas Using Hyperpolarized C Pyruvate MRI. Cancers. 10. PMID 30189677 DOI: 10.3390/Cancers10090313  0.343
2018 Chapman CH, Braunstein SE, Pouliot J, Noworolski SM, Weinberg V, Cunha A, Kurhanewicz J, Gottschalk AR, Roach MI, Hsu IC. Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy. Journal of Contemporary Brachytherapy. 10: 193-201. PMID 30038638 DOI: 10.5114/Jcb.2018.76881  0.326
2018 Lee JE, Diederich CJ, Bok R, Sriram R, Santos RD, Noworolski SM, Salgaonkar VA, Adams MS, Vigneron DB, Kurhanewicz J. Assessing high-intensity focused ultrasound treatment of prostate cancer with hyperpolarized C dual-agent imaging of metabolism and perfusion. Nmr in Biomedicine. e3962. PMID 30022550 DOI: 10.1002/Nbm.3962  0.483
2018 Maidens J, Gordon JW, Chen HY, Park I, Van Criekinge M, Milshteyn E, Bok R, Aggarwal R, Ferrone M, Slater JB, Kurhanewicz J, Vigneron DB, Arcak M, Larson PEZ. Spatio-temporally constrained reconstruction for hyperpolarized carbon-13 MRI using kinetic models. Ieee Transactions On Medical Imaging. PMID 29994332 DOI: 10.1109/Tmi.2018.2844246  0.331
2018 Sriram R, Nguyen J, Santos JD, Nguyen L, Sun J, Vigneron S, Van Criekinge M, Kurhanewicz J, MacKenzie JD. Molecular detection of inflammation in cell models using hyperpolarized C-pyruvate. Theranostics. 8: 3400-3407. PMID 29930738 DOI: 10.7150/Thno.24322  0.318
2018 Qin H, Carroll VN, Sriram R, Villanueva-Meyer JE, von Morze C, Wang ZJ, Mutch CA, Keshari KR, Flavell RR, Kurhanewicz J, Wilson DM. Imaging glutathione depletion in the rat brain using ascorbate-derived hyperpolarized MR and PET probes. Scientific Reports. 8: 7928. PMID 29786697 DOI: 10.1038/S41598-018-26296-6  0.34
2018 Truillet C, Parker MFL, Huynh LT, Wei J, Jami KM, Wang YH, Shen YS, Sriram R, Wilson DM, Kurhanewicz J, Evans MJ. Measuring glucocorticoid receptor expression with PET. Oncotarget. 9: 20399-20408. PMID 29755660 DOI: 10.18632/Oncotarget.24911  0.344
2018 Taglang C, Korenchan DE, von Morze C, Yu J, Najac C, Wang S, Blecha JE, Subramaniam S, Bok R, VanBrocklin HF, Vigneron DB, Ronen SM, Sriram R, Kurhanewicz J, Wilson DM, et al. Late-stage deuteration of C-enriched substrates for T prolongation in hyperpolarized C MRI. Chemical Communications (Cambridge, England). PMID 29726563 DOI: 10.1039/C8Cc02246A  0.388
2018 Chen HY, Larson PEZ, Gordon JW, Bok RA, Ferrone M, van Criekinge M, Carvajal L, Cao P, Pauly JM, Kerr AB, Park I, Slater JB, Nelson SJ, Munster PN, Aggarwal R, ... Kurhanewicz J, et al. Technique development of 3D dynamic CS-EPSI for hyperpolarizedC pyruvate MR molecular imaging of human prostate cancer. Magnetic Resonance in Medicine. PMID 29575178 DOI: 10.1002/Mrm.27179  0.503
2018 von Morze C, Reed GD, Larson PE, Mammoli D, Chen AP, Tropp J, Van Criekinge M, Ohliger MA, Kurhanewicz J, Vigneron DB, Merritt ME. In vivo hyperpolarization transfer in a clinical MRI scanner. Magnetic Resonance in Medicine. PMID 29488244 DOI: 10.1002/Mrm.27154  0.304
2018 Sriram R, Sun J, Villanueva-Meyer J, Mutch C, DeLos Santos J, Peters J, Korenchan DE, Neumann K, Van Criekinge M, Kurhanewicz J, Rosenberg O, Wilson D, Ohliger MA. Detection of bacteria-specific metabolism using hyperpolarized [2-13C] pyruvate. Acs Infectious Diseases. PMID 29405697 DOI: 10.1021/Acsinfecdis.7B00234  0.377
2018 Morze CV, Allu PKR, Chang GY, Marco-Rius I, Milshteyn E, Wang ZJ, Ohliger MA, Gleason CE, Kurhanewicz J, Vigneron DB, Pearce D. Non-invasive detection of divergent metabolic signals in insulin deficiency vs. insulin resistance in vivo. Scientific Reports. 8: 2088. PMID 29391429 DOI: 10.1038/S41598-018-20264-W  0.305
2018 Park I, Larson PEZ, Gordon JW, Carvajal L, Chen HY, Bok R, Van Criekinge M, Ferrone M, Slater JB, Xu D, Kurhanewicz J, Vigneron DB, Chang S, Nelson SJ. Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies. Magnetic Resonance in Medicine. PMID 29322616 DOI: 10.1002/Mrm.27077  0.397
2018 Aggarwal RR, Zhu Z, Ohliger M, Gordon J, Bok RA, Slater J, Kurhanewicz JV, Boyd E, Calabrese S, Sotto CE, Vigneron DB, Munster PN. Hyperpolarized C-13 pyuvate metabolic MR imaging of solid tumor liver metastases as a biomarker of PI3K/mTOR pathway activity. Journal of Clinical Oncology. 36: e24168-e24168. DOI: 10.1200/Jco.2018.36.15_Suppl.E24168  0.302
2018 Geng H, Tiret B, Gao H, Kadoch C, Lu M, Chen L, Park I, Melkus G, Elkhaled A, Kurhanewicz J, Drew L, Degorce S, Mayo M, Dillman K, Anjum R, et al. Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NFkB Activation in Preclinical Patient-Derived Models of CNS Lymphoma Blood. 132: 2840-2840. DOI: 10.1182/Blood-2018-99-117625  0.423
2017 von Morze C, Tropp J, Chen AP, Marco-Rius I, Van Criekinge M, Skloss TW, Mammoli D, Kurhanewicz J, Vigneron DB, Ohliger MA, Merritt ME. Sensitivity enhancement for detection of hyperpolarized 13 C MRI probes with 1 H spin coupling introduced by enzymatic transformation in vivo. Magnetic Resonance in Medicine. PMID 29193287 DOI: 10.1002/Mrm.27000  0.344
2017 Leapman MS, Wang ZJ, Behr SC, Kurhanewicz J, Zagoria RJ, Carroll PR, Westphalen AC. Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer. Radiologia Brasileira. 50: 299-307. PMID 29085163 DOI: 10.1590/0100-3984.2016.0117  0.46
2017 Starobinets O, Simko JP, Kuchinsky K, Kornak J, Carroll PR, Greene KL, Kurhanewicz J, Noworolski SM. Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standard. Nmr in Biomedicine. PMID 28961382 DOI: 10.1002/Nbm.3796  0.437
2017 Aggarwal R, Vigneron DB, Kurhanewicz J. Hyperpolarized 1-[(13)C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Androgen Ablation Therapy in Prostate Cancer. European Urology. PMID 28765011 DOI: 10.1016/J.Eururo.2017.07.022  0.504
2017 Shin PJ, Zhu Z, Camarda R, Bok RA, Zhou AY, Kurhanewicz J, Goga A, Vigneron DB. Cancer recurrence monitoring using hyperpolarized [1-(13)C]pyruvate metabolic imaging in murine breast cancer model. Magnetic Resonance Imaging. PMID 28716678 DOI: 10.1016/J.Mri.2017.07.014  0.402
2017 Baligand C, Qin H, True-Yasaki A, Gordon JW, von Morze C, Santos JD, Wilson DM, Raffai R, Cowley PM, Baker AJ, Kurhanewicz J, Lovett DH, Wang ZJ. Hyperpolarized (13) C magnetic resonance evaluation of renal ischemia reperfusion injury in a murine model. Nmr in Biomedicine. PMID 28708304 DOI: 10.1002/Nbm.3765  0.353
2017 Chen HY, Larson PEZ, Bok RA, von Morze C, Sriram R, Delos Santos R, Delos Santos J, Gordon JW, Bahrami N, Ferrone M, Kurhanewicz J, Vigneron DB. Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion. Cancer Research. PMID 28428273 DOI: 10.1158/0008-5472.Can-16-2083  0.513
2017 Jalbert LE, Elkhaled A, Phillips JJ, Neill E, Williams A, Crane JC, Olson MP, Molinaro AM, Berger MS, Kurhanewicz J, Ronen SM, Chang SM, Nelson SJ. Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma. Scientific Reports. 7: 44792. PMID 28327577 DOI: 10.1038/Srep44792  0.335
2017 Korenchan DE, Taglang C, von Morze C, Blecha JE, Gordon JW, Sriram R, Larson PE, Vigneron DB, VanBrocklin HF, Kurhanewicz J, Wilson DM, Flavell RR. Dicarboxylic acids as pH sensors for hyperpolarized (13)C magnetic resonance spectroscopic imaging. The Analyst. PMID 28322385 DOI: 10.1039/C7An00076F  0.394
2017 Starobinets O, Kurhanewicz J, Noworolski SM. Improved multiparametric MRI discrimination between low-risk prostate cancer and benign tissues in a small cohort of 5α-reductase inhibitor treated individuals as compared with an untreated cohort. Nmr in Biomedicine. PMID 28164396 DOI: 10.1002/Nbm.3696  0.462
2017 Milshteyn E, von Morze C, Reed GD, Shang H, Shin PJ, Zhu Z, Chen HY, Bok R, Goga A, Kurhanewicz J, Larson PE, Vigneron DB. Development of High Resolution 3D Hyperpolarized Carbon-13 MR Molecular Imaging Techniques. Magnetic Resonance Imaging. PMID 28077268 DOI: 10.1016/J.Mri.2017.01.003  0.429
2017 Park I, Elkhaled A, Yang X, Zhai Y, Sriram R, Korenchan D, Kurhanewicz J, Cunha A, Hsu I, Nelson S, Mueller S. Pdtm-20. Noninvasive Assessment Of Treatment Response For Diffuse Intrinsic Pontine Glioma Using Hyperpolarized 13C Metabolic Imaging Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox083.031  0.395
2016 Shang H, Sukumar S, von Morze C, Bok RA, Marco-Rius I, Kerr A, Reed GD, Milshteyn E, Ohliger MA, Kurhanewicz J, Larson PE, Pauly JM, Vigneron DB. Spectrally selective three-dimensional dynamic balanced steady-state free precession for hyperpolarized C-13 metabolic imaging with spectrally selective radiofrequency pulses. Magnetic Resonance in Medicine. PMID 27770458 DOI: 10.1002/Mrm.26480  0.431
2016 Reed GD, von Morze C, Verkman AS, Koelsch BL, Chaumeil MM, Lustig M, Ronen SM, Bok RA, Sands JM, Larson PE, Wang ZJ, Larsen JH, Kurhanewicz J, Vigneron DB. Imaging Renal Urea Handling in Rats at Millimeter Resolution using Hyperpolarized Magnetic Resonance Relaxometry. Tomography : a Journal For Imaging Research. 2: 125-135. PMID 27570835 DOI: 10.18383/j.tom.2016.00127  0.753
2016 Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y. (18)F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 160220. PMID 27513849 DOI: 10.1148/Radiol.2016160220  0.436
2016 Koelsch BL, Sriram R, Keshari KR, Leon Swisher C, Van Criekinge M, Sukumar S, Vigneron DB, Wang ZJ, Larson PE, Kurhanewicz J. Separation of extra- and intracellular metabolites using hyperpolarized (13)C diffusion weighted MR. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 270: 115-123. PMID 27434780 DOI: 10.1016/J.Jmr.2016.07.002  0.765
2016 Ohliger MA, von Morze C, Marco-Rius I, Gordon J, Larson PE, Bok R, Chen HY, Kurhanewicz J, Vigneron D. Combining hyperpolarized (13) C MRI with a liver-specific gadolinium contrast agent for selective assessment of hepatocyte metabolism. Magnetic Resonance in Medicine. PMID 27298073 DOI: 10.1002/Mrm.26296  0.367
2016 Starobinets O, Korn N, Iqbal S, Noworolski SM, Zagoria R, Kurhanewicz J, Westphalen AC. Practical aspects of prostate MRI: hardware and software considerations, protocols, and patient preparation. Abdominal Radiology (New York). 41: 817-30. PMID 27193785 DOI: 10.1007/S00261-015-0590-X  0.436
2016 von Morze C, Chang GY, Larson PE, Shang H, Allu PK, Bok RA, Crane JC, Olson MP, Tan CT, Marco-Rius I, Nelson SJ, Kurhanewicz J, Pearce D, Vigneron DB. Detection of localized changes in the metabolism of hyperpolarized gluconeogenic precursors (13) C-lactate and (13) C-pyruvate in kidney and liver. Magnetic Resonance in Medicine. PMID 27098724 DOI: 10.1002/Mrm.26245  0.347
2016 Marco-Rius I, Cao P, von Morze C, Merritt M, Moreno KX, Chang GY, Ohliger MA, Pearce D, Kurhanewicz J, Larson PE, Vigneron DB. Multiband spectral-spatial RF excitation for hyperpolarized [2-(13) C]dihydroxyacetone (13) C-MR metabolism studies. Magnetic Resonance in Medicine. PMID 27017966 DOI: 10.1002/Mrm.26226  0.356
2016 Korenchan DE, Flavell RR, Baligand C, Sriram R, Neumann K, Sukumar S, VanBrocklin H, Vigneron DB, Wilson DM, Kurhanewicz J. Dynamic nuclear polarization of biocompatible (13)C-enriched carbonates for in vivo pH imaging. Chemical Communications (Cambridge, England). PMID 26792559 DOI: 10.1039/C5Cc09724J  0.441
2016 Kurhanewicz J. Abstract SY19-03: Translation of hyperpolarized13C imaging to the clinic Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Sy19-03  0.516
2016 Park I, Elkhaled A, Yang X, Zhai Y, Sriram R, Korenchan D, Kurhanewicz J, Nelson S, Mueller S. Pdtb-05. Developing A Noninvasive Imaging Marker For Assessing The Response Of Diffuse Intrinsic Pontine Glioma To Panobinostat Using Hyperpolarized Carbon-13 Mr Metabolic Imaging Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.625  0.381
2016 Park I, Elkhaled A, Yang X, Sriram R, Korenchan D, Kurhanewicz J, Nelson S, Mueller S. Hg-117Assessing The Response Of Diffuse Intrinsic Pontine Glioma To Panobinostat Using Hyperpolarized 13C Magnetic Resonance Metabolic Imaging Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now073.113  0.429
2016 Leapman M, Wang Z, Behr S, Kurhanewicz J, Zagoria R, Carroll P, Guimarães C, Westphalen A. Mp79-10 Proton Magnetic Resonance Imaging Spectroscopy Improves Prediction Of High Grade Prostate Cancer When Integrated In Pi-Rads 2 The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2008  0.317
2015 Westphalen AC, Noworolski SM, Harisinghani M, Jhaveri KS, Raman SS, Rosenkrantz AB, Wang ZJ, Zagoria RJ, Kurhanewicz J. High-Resolution 3-T Endorectal Prostate MRI: A Multireader Study of Radiologist Preference and Perceived Interpretive Quality of 2D and 3D T2-Weighted Fast Spin-Echo MR Images. Ajr. American Journal of Roentgenology. 1-6. PMID 26491891 DOI: 10.2214/Ajr.14.14065  0.432
2015 Flavell RR, von Morze C, Blecha JE, Korenchan DE, Van Criekinge M, Sriram R, Gordon JW, Chen HY, Subramaniam S, Bok RA, Wang ZJ, Vigneron DB, Larson PE, Kurhanewicz J, Wilson DM. Application of Good's buffers to pH imaging using hyperpolarized (13)C MRI. Chemical Communications (Cambridge, England). PMID 26257040 DOI: 10.1039/C5Cc05348J  0.367
2015 Sriram R, Van Criekinge M, Hansen A, Wang ZJ, Vigneron DB, Wilson DM, Keshari KR, Kurhanewicz J. Real-time measurement of hyperpolarized lactate production and efflux as a biomarker of tumor aggressiveness in an MR compatible 3D cell culture bioreactor. Nmr in Biomedicine. PMID 26202449 DOI: 10.1002/Nbm.3354  0.394
2015 Keshari KR, Wilson DM, Van Criekinge M, Sriram R, Koelsch BL, Wang ZJ, VanBrocklin HF, Peehl DM, O'Brien T, Sampath D, Carano RA, Kurhanewicz J. Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor. The Prostate. 75: 1601-9. PMID 26177608 DOI: 10.1002/Pros.23036  0.776
2015 Leon Swisher C, Koelsch B, Sukumar S, Sriram R, Santos RD, Wang ZJ, Kurhanewicz J, Vigneron D, Larson P. Dynamic UltraFast 2D EXchange SpectroscopY (UF-EXSY) of hyperpolarized substrates. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 257: 102-109. PMID 26117655 DOI: 10.1016/J.Jmr.2015.05.011  0.744
2015 von Morze C, Bok RA, Ohliger MA, Zhu Z, Vigneron DB, Kurhanewicz J. Hyperpolarized [(13) C]ketobutyrate, a molecular analog of pyruvate with modified specificity for LDH isoforms. Magnetic Resonance in Medicine. PMID 26059096 DOI: 10.1002/Mrm.25716  0.376
2015 Tufts L, Shet Vishnudas K, Fu E, Kurhanewicz J, Ries M, Alliston T, Li X. Correlating high-resolution magic angle spinning NMR spectroscopy and gene analysis in osteoarthritic cartilage. Nmr in Biomedicine. 28: 523-8. PMID 25761416 DOI: 10.1002/Nbm.3285  0.302
2015 Koelsch BL, Reed GD, Keshari KR, Chaumeil MM, Bok R, Ronen SM, Vigneron DB, Kurhanewicz J, Larson PE. Rapid in vivo apparent diffusion coefficient mapping of hyperpolarized (13) C metabolites. Magnetic Resonance in Medicine. 74: 622-33. PMID 25213126 DOI: 10.1002/Mrm.25422  0.776
2015 Korn N, Kurhanewicz J, Banerjee S, Starobinets O, Saritas E, Noworolski S. Reduced-FOV excitation decreases susceptibility artifact in diffusion-weighted MRI with endorectal coil for prostate cancer detection. Magnetic Resonance Imaging. 33: 56-62. PMID 25200645 DOI: 10.1016/J.Mri.2014.08.040  0.417
2015 Keshari KR, Wilson DM, Sai V, Bok R, Jen KY, Larson P, Van Criekinge M, Kurhanewicz J, Wang ZJ. Noninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized 13C dehydroascorbate magnetic resonance. Diabetes. 64: 344-52. PMID 25187363 DOI: 10.2337/Db13-1829  0.306
2015 Salgaonkar V, Ozhinsky E, Rieke V, Prakash P, Hsu I, Kurhanewicz J, Diederich C. Implementation of sonication and feedback control strategies for targeted hyperthermia in prostate with a commercial MR-guided endorectal ultrasound ablation array Journal of Therapeutic Ultrasound. 3. DOI: 10.1186/2050-5736-3-S1-O62  0.345
2015 Lee JE, Diederich CJ, Salgaonkar VA, Bok R, Taylor AG, Kurhanewicz J. Evaluation of high intensity focused ultrasound ablation of prostate tumor with hyperpolarized 13C imaging biomarkers Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9326. DOI: 10.1117/12.2080476  0.498
2014 Toth R, Traughber B, Ellis R, Kurhanewicz J, Madabhushi A. A Domain Constrained Deformable (DoCD) Model for Co-registration of Pre- and Post-Radiated Prostate MRI. Neurocomputing. 114: 3-12. PMID 25267873 DOI: 10.1016/J.Neucom.2014.01.058  0.416
2014 Wilson DM, Kurhanewicz J. Hyperpolarized 13C MR for molecular imaging of prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1567-72. PMID 25168625 DOI: 10.2967/Jnumed.114.141705  0.469
2014 Jung AJ, Westphalen AC, Kurhanewicz J, Wang ZJ, Carroll PR, Simko JP, Coakley FV. Clinical utility of endorectal MRI-guided prostate biopsy: preliminary experience. Journal of Magnetic Resonance Imaging : Jmri. 40: 314-23. PMID 24924999 DOI: 10.1002/Jmri.24383  0.421
2014 Flavell RR, Westphalen AC, Liang C, Sotto CC, Noworolski SM, Vigneron DB, Wang ZJ, Kurhanewicz J. Abnormal findings on multiparametric prostate magnetic resonance imaging predict subsequent biopsy upgrade in patients with low risk prostate cancer managed with active surveillance. Abdominal Imaging. 39: 1027-35. PMID 24740760 DOI: 10.1007/S00261-014-0136-7  0.455
2014 Salgaonkar VA, Prakash P, Rieke V, Ozhinsky E, Plata J, Kurhanewicz J, Hsu IC, Diederich CJ. Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array. Medical Physics. 41: 033301. PMID 24593742 DOI: 10.1118/1.4866226  0.384
2014 Anwar M, Westphalen AC, Jung AJ, Noworolski SM, Simko JP, Kurhanewicz J, Roach M, Carroll PR, Coakley FV. Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: quantitative analysis of imaging contour compared to whole-mount histopathology. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 110: 303-8. PMID 24444524 DOI: 10.1016/J.Radonc.2013.12.003  0.469
2014 Aggarwal R, Kurhanewicz J. The changing role of imaging in clinical care. Nature Reviews. Urology. 11: 75-7. PMID 24418808 DOI: 10.1038/Nrurol.2013.319  0.434
2014 von Morze C, Bok RA, Reed GD, Ardenkjaer-Larsen JH, Kurhanewicz J, Vigneron DB. Simultaneous multiagent hyperpolarized (13)C perfusion imaging. Magnetic Resonance in Medicine. 72: 1599-609. PMID 24382698 DOI: 10.1002/Mrm.25071  0.422
2014 Reed GD, von Morze C, Bok R, Koelsch BL, Van Criekinge M, Smith KJ, Hong Shang, Larson PE, Kurhanewicz J, Vigneron DB. High resolution (13)C MRI with hyperpolarized urea: in vivo T(2) mapping and (15)N labeling effects. Ieee Transactions On Medical Imaging. 33: 362-71. PMID 24235273 DOI: 10.1109/Tmi.2013.2285120  0.768
2014 Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, et al. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel. Bju International. 113: 218-27. PMID 24215670 DOI: 10.1111/Bju.12243  0.44
2014 Starobinets O, Guo R, Simko JP, Kuchinsky K, Kurhanewicz J, Carroll PR, Greene KL, Noworolski SM. Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded prostates. Journal of Magnetic Resonance Imaging : Jmri. 39: 1223-9. PMID 24136783 DOI: 10.1002/Jmri.24287  0.462
2014 Zhang VY, Westphalen A, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. The role of metabolic imaging in radiation therapy of prostate cancer. Nmr in Biomedicine. 27: 100-11. PMID 23940096 DOI: 10.1002/Nbm.3007  0.727
2014 Chang ST, Westphalen AC, Jha P, Jung AJ, Carroll PR, Kurhanewicz J, Coakley FV. Endorectal MRI and MR spectroscopic imaging of prostate cancer: developing selection criteria for MR-guided focal therapy. Journal of Magnetic Resonance Imaging : Jmri. 39: 519-25. PMID 23681669 DOI: 10.1002/Jmri.24187  0.481
2014 Swisher CL, Larson PE, Kruttwig K, Kerr AB, Hu S, Bok RA, Goga A, Pauly JM, Nelson SJ, Kurhanewicz J, Vigneron DB. Quantitative measurement of cancer metabolism using stimulated echo hyperpolarized carbon-13 MRS. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 71: 1-11. PMID 23412881 DOI: 10.1002/Mrm.24634  0.411
2014 Sriram R, Keshari KR, Criekinge MV, Kurhanewicz J, Wilson DM, Peehl DM, Bok R, Zhen WJ. Abstract B37: Patient-derived tissue culture model systems of renal cell carcinoma for development of clinically translatable metabolic biomarkers Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Modorg-B37  0.431
2014 Ginsburg SB, Rusu M, Kurhanewicz J, Madabhushi A. Computer extracted texture features on T2w MRI to predict biochemical recurrence following radiation therapy for prostate cancer Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9035. DOI: 10.1117/12.2043937  0.363
2014 Rusu M, Kurhanewicz J, Tewari A, Madabhushi A. A prostate MRI atlas of biochemical failures following cancer treatment Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9035. DOI: 10.1117/12.2043775  0.428
2014 Braunstein S, Pouliot J, Kurhanewicz J, Weinberg V, Cunha JAN, Chang A, Gottschalk A, Roach M, I-Chow H. Phase I Study of Targeting Dominant Intraprostatic Lesion Using Functional Imaging with MR Spectroscopy and High-Dose-Rate Brachytherapy Brachytherapy. 13: S72. DOI: 10.1016/J.Brachy.2014.02.326  0.316
2013 Reed G, von Morze C, Bok R, Koelsch B, Smith K, van Criekinge M, Larson P, Kurhanewicz J, Vigneron D. WE-C-116-02: High Resolution C-13 MRI with Hyperpolarized [C-13,N-15] Urea. Medical Physics. 40: 484. PMID 28518648 DOI: 10.1118/1.4815564  0.764
2013 Crehange G, Krishnamurthy D, Cunha JA, Pickett B, Kurhanewicz J, Hsu IC, Gottschalk AR, Shinohara K, Roach M, Pouliot J. Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: implications for focal salvage brachytherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 109: 246-50. PMID 24231238 DOI: 10.1016/J.Radonc.2013.10.028  0.402
2013 Nelson SJ, Kurhanewicz J, Vigneron DB, Larson PE, Harzstark AL, Ferrone M, van Criekinge M, Chang JW, Bok R, Park I, Reed G, Carvajal L, Small EJ, Munster P, Weinberg VK, et al. Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate. Science Translational Medicine. 5: 198ra108. PMID 23946197 DOI: 10.1126/Scitranslmed.3006070  0.52
2013 Keshari KR, Sai V, Wang ZJ, Vanbrocklin HF, Kurhanewicz J, Wilson DM. Hyperpolarized [1-13C]dehydroascorbate MR spectroscopy in a murine model of prostate cancer: comparison with 18F-FDG PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 922-8. PMID 23575993 DOI: 10.2967/Jnumed.112.115402  0.438
2013 Keshari KR, Sriram R, Van Criekinge M, Wilson DM, Wang ZJ, Vigneron DB, Peehl DM, Kurhanewicz J. Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactor. The Prostate. 73: 1171-81. PMID 23532911 DOI: 10.1002/Pros.22665  0.495
2013 Koelsch BL, Keshari KR, Peeters TH, Larson PE, Wilson DM, Kurhanewicz J. Diffusion MR of hyperpolarized 13C molecules in solution. The Analyst. 138: 1011-4. PMID 23304699 DOI: 10.1039/C2An36715G  0.761
2013 Tiwari P, Kurhanewicz J, Madabhushi A. Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRS. Medical Image Analysis. 17: 219-35. PMID 23294985 DOI: 10.1016/J.Media.2012.10.004  0.444
2013 Ohliger MA, Larson PE, Bok RA, Shin P, Hu S, Tropp J, Robb F, Carvajal L, Nelson SJ, Kurhanewicz J, Vigneron DB. Combined parallel and partial fourier MR reconstruction for accelerated 8-channel hyperpolarized carbon-13 in vivo magnetic resonance Spectroscopic imaging (MRSI). Journal of Magnetic Resonance Imaging : Jmri. 38: 701-13. PMID 23293097 DOI: 10.1002/Jmri.23989  0.428
2013 Larson PE, Hurd RE, Kerr AB, Pauly JM, Bok RA, Kurhanewicz J, Vigneron DB. Perfusion and diffusion sensitive 13C stimulated-echo MRSI for metabolic imaging of cancer. Magnetic Resonance Imaging. 31: 635-42. PMID 23260391 DOI: 10.1016/J.Mri.2012.10.020  0.502
2013 LeBeau AM, Lee M, Murphy ST, Hann BC, Warren RS, Delos Santos R, Kurhanewicz J, Hanash SM, VanBrocklin HF, Craik CS. Imaging a functional tumorigenic biomarker in the transformed epithelium. Proceedings of the National Academy of Sciences of the United States of America. 110: 93-8. PMID 23248318 DOI: 10.1073/Pnas.1218694110  0.334
2013 Keshari KR, Sriram R, Koelsch BL, Van Criekinge M, Wilson DM, Kurhanewicz J, Wang ZJ. Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomas. Cancer Research. 73: 529-38. PMID 23204238 DOI: 10.1158/0008-5472.Can-12-3461  0.769
2013 Hu S, Larson PE, Vancriekinge M, Leach AM, Park I, Leon C, Zhou J, Shin PJ, Reed G, Keselman P, von Morze C, Yoshihara H, Bok RA, Nelson SJ, Kurhanewicz J, et al. Rapid sequential injections of hyperpolarized [1-¹³C]pyruvate in vivo using a sub-kelvin, multi-sample DNP polarizer. Magnetic Resonance Imaging. 31: 490-6. PMID 23107275 DOI: 10.1016/J.Mri.2012.09.002  0.403
2013 von Morze C, Sukumar S, Reed GD, Larson PE, Bok RA, Kurhanewicz J, Vigneron DB. Frequency-specific SSFP for hyperpolarized ¹³C metabolic imaging at 14.1 T. Magnetic Resonance Imaging. 31: 163-70. PMID 22898680 DOI: 10.1016/J.Mri.2012.06.037  0.483
2013 Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, Weinberg V, Gottschalk AR, Kurhanewicz J, Shinohara K, Roach M. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 85: 370-7. PMID 22672747 DOI: 10.1016/J.Ijrobp.2012.04.028  0.46
2013 Salgaonkar VA, Rieke V, Ozhinsky E, Prakash P, Plata J, Kurhanewicz J, Hsu IC, Diederich CJ. Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MRI-guided endorectal high intensity focused ultrasound ablation array Journal of the Acoustical Society of America. 134: 4180-4180. DOI: 10.1121/1.4831325  0.361
2013 Salgaonkar VA, Prakash P, Plata J, Holbrook A, Rieke V, Kurhanewicz J, Hsu IC, Diederich CJ. Targeted hyperthermia in prostate with an MR-guided endorectal ultrasound phased array: Patient specific modeling and preliminary experiments Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8584. DOI: 10.1117/12.2004609  0.38
2012 Gulley JL, Emberton M, Kurhanewicz J, Choyke P. Progress in prostate cancer imaging. Urologic Oncology. 30: 938-9. PMID 23218070 DOI: 10.1016/J.Urolonc.2012.09.008  0.437
2012 Jung AJ, Coakley FV, Shinohara K, Carroll PR, Kurhanewicz J, Cowan JE, Westphalen AC. Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound. Clinical Imaging. 36: 547-52. PMID 22920360 DOI: 10.1016/J.Clinimag.2011.11.028  0.471
2012 Hu S, Yoshihara HA, Bok R, Zhou J, Zhu M, Kurhanewicz J, Vigneron DB. Use of hyperpolarized [1-13C]pyruvate and [2-13C]pyruvate to probe the effects of the anticancer agent dichloroacetate on mitochondrial metabolism in vivo in the normal rat. Magnetic Resonance Imaging. 30: 1367-72. PMID 22819176 DOI: 10.1016/J.Mri.2012.05.012  0.356
2012 Créhange G, Chen CP, Hsu CC, Kased N, Coakley FV, Kurhanewicz J, Roach M. Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm. Cancer Treatment Reviews. 38: 956-67. PMID 22703831 DOI: 10.1016/J.Ctrv.2012.05.005  0.38
2012 Keshari KR, Kurhanewicz J, Macdonald JM, Wilson DM. Generating contrast in hyperpolarized 13C MRI using ligand-receptor interactions. The Analyst. 137: 3427-9. PMID 22655289 DOI: 10.1039/C2An35406C  0.375
2012 Westphalen AC, Reed GD, Vinh PP, Sotto C, Vigneron DB, Kurhanewicz J. Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer. Journal of Magnetic Resonance Imaging : Jmri. 36: 430-7. PMID 22535708 DOI: 10.1002/Jmri.23672  0.458
2012 von Morze C, Bok RA, Sands JM, Kurhanewicz J, Vigneron DB. Monitoring urea transport in rat kidney in vivo using hyperpolarized ¹³C magnetic resonance imaging. American Journal of Physiology. Renal Physiology. 302: F1658-62. PMID 22492940 DOI: 10.1152/Ajprenal.00640.2011  0.403
2012 Reed GD, Larson PE, Morze Cv, Bok R, Lustig M, Kerr AB, Pauly JM, Kurhanewicz J, Vigneron DB. A method for simultaneous echo planar imaging of hyperpolarized ¹³C pyruvate and ¹³C lactate. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 217: 41-7. PMID 22405760 DOI: 10.1016/J.Jmr.2012.02.008  0.396
2012 Arrayeh E, Westphalen AC, Kurhanewicz J, Roach M, Jung AJ, Carroll PR, Coakley FV. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. International Journal of Radiation Oncology, Biology, Physics. 82: e787-93. PMID 22331003 DOI: 10.1016/J.Ijrobp.2011.11.030  0.422
2012 Ahmed HU, Akin O, Coleman JA, Crane S, Emberton M, Goldenberg L, Hricak H, Kattan MW, Kurhanewicz J, Moore CM, Parker C, Polascik TJ, Scardino P, van As N, Villers A, et al. Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer. Bju International. 109: 1636-47. PMID 22077593 DOI: 10.1111/J.1464-410X.2011.10633.X  0.409
2012 Larson PE, Kerr AB, Reed GD, Hurd RE, Kurhanewicz J, Pauly JM, Vigneron DB. Generating super stimulated-echoes in MRI and their application to hyperpolarized C-13 diffusion metabolic imaging. Ieee Transactions On Medical Imaging. 31: 265-75. PMID 22027366 DOI: 10.1109/Tmi.2011.2168235  0.38
2012 Tiwari P, Viswanath S, Kurhanewicz J, Sridhar A, Madabhushi A. Multimodal wavelet embedding representation for data combination (MaWERiC): integrating magnetic resonance imaging and spectroscopy for prostate cancer detection. Nmr in Biomedicine. 25: 607-19. PMID 21960175 DOI: 10.1002/Nbm.1777  0.449
2012 Shet K, Siddiqui SM, Yoshihara H, Kurhanewicz J, Ries M, Li X. High-resolution magic angle spinning NMR spectroscopy of human osteoarthritic cartilage. Nmr in Biomedicine. 25: 538-44. PMID 21850648 DOI: 10.1002/Nbm.1769  0.308
2012 Anwar MM, Westphalen AC, Jung A, Noworolski S, Kurhanewicz J, Simko JP, Carroll PR, Coakley FV. Role of Endorectal MRI and MRSI in Defining the Dominant Intraprostatic Lesion in Prostate Cancer: Quantitative Analysis of Imaging Contour Compared to Whole-Mount Histopathology International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1065  0.443
2011 Viswanath S, Tiwari P, Chappelow J, Toth R, Kurhanewicz J, Madabhushi A. CADOnc(©): An Integrated Toolkit For Evaluating Radiation Therapy Related Changes In The Prostate Using Multiparametric MRI. Proceedings / Ieee International Symposium On Biomedical Imaging: From Nano to Macro. Ieee International Symposium On Biomedical Imaging. 2011: 2095-2098. PMID 25360226 DOI: 10.1109/ISBI.2011.5872825  0.388
2011 Reed G, Cunha JA, Noworolski S, Kurhanewicz J, Vigneron D, Hsu IC, Pouliot J. Interactive, multi-modality image registrations for combined MRI/MRSI-planned HDR prostate brachytherapy. Journal of Contemporary Brachytherapy. 3: 26-31. PMID 23606866 DOI: 10.5114/Jcb.2011.21040  0.412
2011 Costello LC, Franklin RB, Zou J, Feng P, Bok R, Swanson MG, Kurhanewicz J. Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model. Cancer Biology & Therapy. 12: 1078-84. PMID 22156800 DOI: 10.4161/Cbt.12.12.18367  0.423
2011 Muglia VF, Westphalen AC, Wang ZJ, Kurhanewicz J, Carroll PR, Coakley FV. Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced disease. Ajr. American Journal of Roentgenology. 197: 1369-74. PMID 22109291 DOI: 10.2214/Ajr.11.6425  0.362
2011 Keshari KR, Kurhanewicz J, Bok R, Larson PE, Vigneron DB, Wilson DM. Hyperpolarized 13C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging. Proceedings of the National Academy of Sciences of the United States of America. 108: 18606-11. PMID 22042839 DOI: 10.1073/Pnas.1106920108  0.385
2011 Majumdar S, Link TM, Steinbach LS, Hu S, Kurhanewicz J. Diagnostic tools and imaging methods in intervertebral disk degeneration. The Orthopedic Clinics of North America. 42: 501-11, viii. PMID 21944587 DOI: 10.1016/J.Ocl.2011.07.007  0.328
2011 Westphalen AC, Koff WJ, Coakley FV, Muglia VF, Neuhaus JM, Marcus RT, Kurhanewicz J, Smith-Bindman R. Prostate cancer: prediction of biochemical failure after external-beam radiation therapy--Kattan nomogram and endorectal MR imaging estimation of tumor volume. Radiology. 261: 477-86. PMID 21873255 DOI: 10.1148/Radiol.11110457  0.389
2011 Hu S, Zhu M, Yoshihara HA, Wilson DM, Keshari KR, Shin P, Reed G, von Morze C, Bok R, Larson PE, Kurhanewicz J, Vigneron DB. In vivo measurement of normal rat intracellular pyruvate and lactate levels after injection of hyperpolarized [1-(13)C]alanine. Magnetic Resonance Imaging. 29: 1035-40. PMID 21855243 DOI: 10.1016/J.Mri.2011.07.001  0.396
2011 Keshari KR, Tsachres H, Iman R, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment Nmr in Biomedicine. 24: 691-699. PMID 21793074 DOI: 10.1002/Nbm.1738  0.412
2011 Chitkara M, Westphalen A, Kurhanewicz J, Qayyum A, Poder L, Reed G, Coakley FV. Magnetic resonance spectroscopic imaging of benign prostatic tissue: findings at 3.0 T compared to 1.5 T-initial experience. Clinical Imaging. 35: 288-93. PMID 21724122 DOI: 10.1016/J.Clinimag.2010.07.005  0.455
2011 Hu S, Balakrishnan A, Bok RA, Anderton B, Larson PE, Nelson SJ, Kurhanewicz J, Vigneron DB, Goga A. 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. Cell Metabolism. 14: 131-42. PMID 21723511 DOI: 10.1016/J.Cmet.2011.04.012  0.374
2011 von Morze C, Larson PE, Hu S, Keshari K, Wilson DM, Ardenkjaer-Larsen JH, Goga A, Bok R, Kurhanewicz J, Vigneron DB. Imaging of blood flow using hyperpolarized [(13)C]urea in preclinical cancer models. Journal of Magnetic Resonance Imaging : Jmri. 33: 692-7. PMID 21563254 DOI: 10.1002/Jmri.22484  0.423
2011 Kumbhani SR, Coakley FV, McCulloch CE, Wang ZJ, Kurhanewicz J, Roach M, Westphalen AC. Endorectal MRI after radiation therapy: questioning the sextant analysis. Journal of Magnetic Resonance Imaging : Jmri. 33: 1086-90. PMID 21509865 DOI: 10.1002/Jmri.22561  0.464
2011 Chung HT, Noworolski SM, Kurhanewicz J, Weinberg V, Roach Iii M. A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer. Bju International. 108: E164-70. PMID 21435153 DOI: 10.1111/J.1464-410X.2010.10061.X  0.454
2011 Kurhanewicz J, Vigneron DB, Brindle K, Chekmenev EY, Comment A, Cunningham CH, Deberardinis RJ, Green GG, Leach MO, Rajan SS, Rizi RR, Ross BD, Warren WS, Malloy CR. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia (New York, N.Y.). 13: 81-97. PMID 21403835 DOI: 10.1593/Neo.101102  0.434
2011 Lippert AR, Keshari KR, Kurhanewicz J, Chang CJ. A hydrogen peroxide-responsive hyperpolarized 13C MRI contrast agent. Journal of the American Chemical Society. 133: 3776-9. PMID 21366297 DOI: 10.1021/Ja111589A  0.364
2011 Toth R, Tiwari P, Rosen M, Reed G, Kurhanewicz J, Kalyanpur A, Pungavkar S, Madabhushi A. A magnetic resonance spectroscopy driven initialization scheme for active shape model based prostate segmentation. Medical Image Analysis. 15: 214-25. PMID 21195016 DOI: 10.1016/J.Media.2010.09.002  0.465
2011 Larson PE, Hu S, Lustig M, Kerr AB, Nelson SJ, Kurhanewicz J, Pauly JM, Vigneron DB. Fast dynamic 3D MR spectroscopic imaging with compressed sensing and multiband excitation pulses for hyperpolarized 13C studies. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 65: 610-9. PMID 20939089 DOI: 10.1002/Mrm.22650  0.453
2011 Carroll PR, Coakley FV, Kurhanewicz J. Magnetic resonance imaging and spectroscopy of prostate cancer. Reviews in Urology. S4-S10. PMID 17021625  0.396
2011 Bet-Lachin A, Jiang F, Chen L, Keshari K, Wilson D, Kurhanewicz J, Rubenstein JL. Metabolic Profiling of CNS Lymphoma and Its Microenvironment Blood. 118: 588-588. DOI: 10.1182/Blood.V118.21.588.588  0.421
2011 Zhang V, Cunha J, Bok R, Hsu I, Scott K, Sukumar S, Kurhanewicz J, Pouliot J. SU-E-J-130: Hyperpolarized 13C Biomarkers of Response to Prostate Cancer Radiation Therapy Medical Physics. 38: 3472-3472. DOI: 10.1118/1.3611897  0.724
2011 Shet K, Liang F, Alliston T, Yoshihara H, Kurhanewicz J, Ries M, Horvai A, Li X. 150 QUANTITATIVE AND HISTOPATHOLOGICAL ANALYSIS OF OSTEO-ARTHRITIC CARTILAGE USING MRI, HRMAS SPECTROSCOPY AND IMMUNO-HISTOCHEMISTRY Osteoarthritis and Cartilage. 19: S76. DOI: 10.1016/S1063-4584(11)60177-5  0.314
2011 Tiwari P, Viswanath S, Kurhanewicz J, Madabhushi A. Weighted combination of multi-parametric MR imaging markers for evaluating radiation therapy related changes in the prostate Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 6963: 80-91. DOI: 10.1007/978-3-642-23944-1_9  0.348
2010 Tiwari P, Kurhanewicz J, Rosen M, Madabhushi A. Semi supervised multi kernel (SeSMiK) graph embedding: identifying aggressive prostate cancer via magnetic resonance imaging and spectroscopy. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 13: 666-73. PMID 20879458 DOI: 10.1007/978-3-642-15711-0_83  0.327
2010 Ratiney H, Albers MJ, Rabeson H, Kurhanewicz J. Semi-parametric time-domain quantification of HR-MAS data from prostate tissue. Nmr in Biomedicine. 23: 1146-57. PMID 20842756 DOI: 10.1002/Nbm.1541  0.402
2010 Noworolski SM, Reed GD, Kurhanewicz J, Vigneron DB. Post-processing correction of the endorectal coil reception effects in MR spectroscopic imaging of the prostate. Journal of Magnetic Resonance Imaging : Jmri. 32: 654-62. PMID 20815064 DOI: 10.1002/Jmri.22258  0.377
2010 Westphalen AC, Coakley FV, Roach M, McCulloch CE, Kurhanewicz J. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection. Radiology. 256: 485-92. PMID 20551184 DOI: 10.1148/Radiol.10092314  0.463
2010 Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, Carroll PR. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. Radiology. 256: 176-83. PMID 20505068 DOI: 10.1148/Radiol.10091147  0.468
2010 Verma S, Rajesh A, Fütterer JJ, Turkbey B, Scheenen TW, Pang Y, Choyke PL, Kurhanewicz J. Prostate MRI and 3D MR spectroscopy: how we do it. Ajr. American Journal of Roentgenology. 194: 1414-26. PMID 20489079 DOI: 10.2214/Ajr.10.4312  0.476
2010 Wilson DM, Keshari KR, Larson PE, Chen AP, Hu S, Van Criekinge M, Bok R, Nelson SJ, Macdonald JM, Vigneron DB, Kurhanewicz J. Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 205: 141-7. PMID 20478721 DOI: 10.1016/J.Jmr.2010.04.012  0.426
2010 Cohn BR, Fukuchi EY, Joe BN, Swanson MG, Kurhanewicz J, Yu J, Caughey AB. Calculation of gestational age in late second and third trimesters by ex vivo magnetic resonance spectroscopy of amniotic fluid. American Journal of Obstetrics and Gynecology. 203: 76.e1-76.e10. PMID 20435286 DOI: 10.1016/J.Ajog.2010.01.046  0.305
2010 Hurd RE, Yen YF, Mayer D, Chen A, Wilson D, Kohler S, Bok R, Vigneron D, Kurhanewicz J, Tropp J, Spielman D, Pfefferbaum A. Metabolic imaging in the anesthetized rat brain using hyperpolarized [1-13C] pyruvate and [1-13C] ethyl pyruvate. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 63: 1137-43. PMID 20432284 DOI: 10.1002/Mrm.22364  0.4
2010 Larson PE, Bok R, Kerr AB, Lustig M, Hu S, Chen AP, Nelson SJ, Pauly JM, Kurhanewicz J, Vigneron DB. Investigation of tumor hyperpolarized [1-13C]-pyruvate dynamics using time-resolved multiband RF excitation echo-planar MRSI. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 63: 582-91. PMID 20187172 DOI: 10.1002/Mrm.22264  0.455
2010 Park I, Larson PE, Zierhut ML, Hu S, Bok R, Ozawa T, Kurhanewicz J, Vigneron DB, Vandenberg SR, James CD, Nelson SJ. Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro-Oncology. 12: 133-44. PMID 20150380 DOI: 10.1093/Neuonc/Nop043  0.424
2010 Ward CS, Venkatesh HS, Chaumeil MM, Brandes AH, Vancriekinge M, Dafni H, Sukumar S, Nelson SJ, Vigneron DB, Kurhanewicz J, James CD, Haas-Kogan DA, Ronen SM. Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. Cancer Research. 70: 1296-305. PMID 20145128 DOI: 10.1158/0008-5472.Can-09-2251  0.427
2010 Aaronson DS, Iman R, Walsh TJ, Kurhanewicz J, Turek PJ. A novel application of 1H magnetic resonance spectroscopy: non-invasive identification of spermatogenesis in men with non-obstructive azoospermia. Human Reproduction (Oxford, England). 25: 847-52. PMID 20124393 DOI: 10.1093/Humrep/Dep475  0.364
2010 Keshari KR, Kurhanewicz J, Jeffries RE, Wilson DM, Dewar BJ, Van Criekinge M, Zierhut M, Vigneron DB, Macdonald JM. Hyperpolarized (13)C spectroscopy and an NMR-compatible bioreactor system for the investigation of real-time cellular metabolism. Magnetic Resonance in Medicine. 63: 322-9. PMID 20099325 DOI: 10.1002/Mrm.22225  0.399
2010 Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Santos RD, Federman S, Shinohara K, Carroll PR, Haqq CM, Swanson MG. Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy. Nmr in Biomedicine. 23: 391-8. PMID 20033906 DOI: 10.1002/Nbm.1474  0.338
2010 Hu S, Lustig M, Balakrishnan A, Larson PE, Bok R, Kurhanewicz J, Nelson SJ, Goga A, Pauly JM, Vigneron DB. 3D compressed sensing for highly accelerated hyperpolarized (13)C MRSI with in vivo applications to transgenic mouse models of cancer. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 63: 312-21. PMID 20017160 DOI: 10.1002/Mrm.22233  0.422
2010 Zierhut ML, Yen YF, Chen AP, Bok R, Albers MJ, Zhang V, Tropp J, Park I, Vigneron DB, Kurhanewicz J, Hurd RE, Nelson SJ. Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 202: 85-92. PMID 19884027 DOI: 10.1016/J.Jmr.2009.10.003  0.703
2010 Lupo JM, Chen AP, Zierhut ML, Bok RA, Cunningham CH, Kurhanewicz J, Vigneron DB, Nelson SJ. Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer. Magnetic Resonance Imaging. 28: 153-62. PMID 19695815 DOI: 10.1016/J.Mri.2009.07.007  0.478
2009 Keshari KR, Wilson DM, Chen AP, Bok R, Larson PE, Hu S, Van Criekinge M, Macdonald JM, Vigneron DB, Kurhanewicz J. Hyperpolarized [2-13C]-fructose: a hemiketal DNP substrate for in vivo metabolic imaging. Journal of the American Chemical Society. 131: 17591-6. PMID 19860409 DOI: 10.1021/Ja9049355  0.453
2009 Zuo J, Saadat E, Romero A, Loo K, Li X, Link TM, Kurhanewicz J, Majumdar S. Assessment of intervertebral disc degeneration with magnetic resonance single-voxel spectroscopy. Magnetic Resonance in Medicine. 62: 1140-6. PMID 19780173 DOI: 10.1002/Mrm.22093  0.336
2009 Levin YS, Albers MJ, Butler TN, Spielman D, Peehl DM, Kurhanewicz J. Methods for metabolic evaluation of prostate cancer cells using proton and (13)C HR-MAS spectroscopy and [3-(13)C] pyruvate as a metabolic substrate. Magnetic Resonance in Medicine. 62: 1091-8. PMID 19780158 DOI: 10.1002/Mrm.22120  0.481
2009 Cohn BR, Joe BN, Zhao S, Kornak J, Zhang VY, Iman R, Kurhanewicz J, Vahidi K, Yu J, Caughey AB, Swanson MG. Quantitative metabolic profiles of 2nd and 3rd trimester human amniotic fluid using (1)H HR-MAS spectroscopy. Magma (New York, N.Y.). 22: 343-52. PMID 19779747 DOI: 10.1007/S10334-009-0184-0  0.678
2009 Westphalen AC, Coakley FV, Kurhanewicz J, Reed G, Wang ZJ, Simko JP. Mucinous adenocarcinoma of the prostate: MRI and MR spectroscopy features. Ajr. American Journal of Roentgenology. 193: W238-43. PMID 19696265 DOI: 10.2214/Ajr.08.1495  0.431
2009 Hu S, Chen AP, Zierhut ML, Bok R, Yen YF, Schroeder MA, Hurd RE, Nelson SJ, Kurhanewicz J, Vigneron DB. In vivo carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 11: 399-407. PMID 19424761 DOI: 10.1007/S11307-009-0218-Z  0.416
2009 Westphalen AC, Kurhanewicz J, Cunha RM, Hsu IC, Kornak J, Zhao S, Coakley FV. T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy. International Braz J Urol : Official Journal of the Brazilian Society of Urology. 35: 171-80; discussion 1. PMID 19409121 DOI: 10.1590/S1677-55382009000200007  0.447
2009 Weinreb JC, Blume JD, Coakley FV, Wheeler TM, Cormack JB, Sotto CK, Cho H, Kawashima A, Tempany-Afdhal CM, Macura KJ, Rosen M, Gerst SR, Kurhanewicz J. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology. 251: 122-33. PMID 19332850 DOI: 10.1148/Radiol.2511080409  0.475
2009 Yen YF, Kohler SJ, Chen AP, Tropp J, Bok R, Wolber J, Albers MJ, Gram KA, Zierhut ML, Park I, Zhang V, Hu S, Nelson SJ, Vigneron DB, Kurhanewicz J, et al. Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C-pyruvate. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 62: 1-10. PMID 19319902 DOI: 10.1002/Mrm.21987  0.724
2009 Wilson DM, Hurd RE, Keshari K, Van Criekinge M, Chen AP, Nelson SJ, Vigneron DB, Kurhanewicz J. Generation of hyperpolarized substrates by secondary labeling with [1,1-13C] acetic anhydride. Proceedings of the National Academy of Sciences of the United States of America. 106: 5503-7. PMID 19276112 DOI: 10.1073/Pnas.0810190106  0.348
2009 Albers MJ, Butler TN, Rahwa I, Bao N, Keshari KR, Swanson MG, Kurhanewicz J. Evaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue. Magnetic Resonance in Medicine. 61: 525-32. PMID 19235261 DOI: 10.1002/Mrm.21808  0.359
2009 Chen AP, Tropp J, Hurd RE, Van Criekinge M, Carvajal LG, Xu D, Kurhanewicz J, Vigneron DB. In vivo hyperpolarized 13C MR spectroscopic imaging with 1H decoupling. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 197: 100-6. PMID 19112035 DOI: 10.1016/J.Jmr.2008.12.004  0.458
2009 Umbehr M, Bachmann LM, Held U, Kessler TM, Sulser T, Weishaupt D, Kurhanewicz J, Steurer J. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. European Urology. 55: 575-90. PMID 18952365 DOI: 10.1016/J.Eururo.2008.10.019  0.452
2009 Joseph T, McKenna DA, Westphalen AC, Coakley FV, Zhao S, Lu Y, Hsu IC, Roach M, Kurhanewicz J. Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 73: 665-71. PMID 18760545 DOI: 10.1016/J.Ijrobp.2008.04.056  0.466
2009 Narayanan R, Kurhanewicz J, Shinohara K, Crawford ED, Simoneau A, Suri JS. Mri-ultrasound registration for targeted prostate biopsy Proceedings - 2009 Ieee International Symposium On Biomedical Imaging: From Nano to Macro, Isbi 2009. 991-994. DOI: 10.1109/ISBI.2009.5193221  0.35
2009 Aaronson DS, Walsh TJ, Iman R, Turek PJ, Kurhanewicz J. A Novel Application Of 1H Magnetic Resonance Spectroscopy: Potential For Non-Invasive Identification Of Spermatogenesis In Men With Non-Obstructive Azoospermia The Journal of Urology. 181: 785-786. DOI: 10.1016/S0022-5347(09)62187-X  0.304
2009 Zhang B, Menzin J, Lee DW, Friedman M, Korn JR, Kurhanewicz J, Dann R. Potentially Avoided Surgeries In Men With Localized, Low-Risk Prostate Cancer Undergoing Active Surveillance: A Model-Based Analysis The Journal of Urology. 181: 193-193. DOI: 10.1016/S0022-5347(09)60555-3  0.33
2009 Menzin J, Zhang B, Lee DW, Friedman M, Korn JR, Kurhanewicz J, Dann R. Life Expectancy For Clinically Localized, Low-Risk Prostate Cancer Patients Undergoing Active Surveillance Vs. Immediate Surgery: A Model-Based Analysis The Journal of Urology. 181: 163-163. DOI: 10.1016/S0022-5347(09)60469-9  0.347
2009 Pickett B, Chen J, Yu N, Weinberg V, Kurhanewicz J, Cory K, Pouliot J, Cunha J, Shinohara K, Roach M. MRI-based Dosimetric Reconstruction with Volumetric Deformation for Patients with Recurrent Prostate Cancer under Evaluation for Salvage Brachytherapy International Journal of Radiation Oncology*Biology*Physics. 75: S332-S333. DOI: 10.1016/J.Ijrobp.2009.07.762  0.405
2009 Pouliot J, Cunha AJ, Reed GD, Noworolski SM, Kurhanewicz J, Hsu IJ. Multi-image fusions and their role in inverse planned high-dose-rate prostate brachytherapy for dose escalation of dominant intraprostatic lesions defined by combined MRI/MRSI Brachytherapy. 8: 113-114. DOI: 10.1016/J.Brachy.2009.03.027  0.37
2008 Nelson SJ, Vigneron D, Kurhanewicz J, Chen A, Bok R, Hurd R. DNP-Hyperpolarized C Magnetic Resonance Metabolic Imaging for Cancer Applications. Applied Magnetic Resonance. 34: 533-544. PMID 20198109 DOI: 10.1007/S00723-008-0136-2  0.463
2008 Kurhanewicz J, Vigneron DB. Advances in MR spectroscopy of the prostate. Magnetic Resonance Imaging Clinics of North America. 16: 697-710, ix-x. PMID 18926432 DOI: 10.1016/J.Mric.2008.07.005  0.51
2008 Albers MJ, Bok R, Chen AP, Cunningham CH, Zierhut ML, Zhang VY, Kohler SJ, Tropp J, Hurd RE, Yen YF, Nelson SJ, Vigneron DB, Kurhanewicz J. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Research. 68: 8607-15. PMID 18922937 DOI: 10.1158/0008-5472.Can-08-0749  0.76
2008 Kim DH, Vahidi K, Caughey AB, Coakley FV, Vigneron DB, Kurhanewicz J, Mow B, Joe BN. In vivo (1)H magnetic resonance spectroscopy of amniotic fluid and fetal lung at 1.5 T: technical challenges. Journal of Magnetic Resonance Imaging : Jmri. 28: 1033-8. PMID 18821604 DOI: 10.1002/Jmri.21528  0.316
2008 Tessem MB, Swanson MG, Keshari KR, Albers MJ, Joun D, Tabatabai ZL, Simko JP, Shinohara K, Nelson SJ, Vigneron DB, Gribbestad IS, Kurhanewicz J. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 60: 510-6. PMID 18727052 DOI: 10.1002/Mrm.21694  0.453
2008 Larson PE, Kerr AB, Chen AP, Lustig MS, Zierhut ML, Hu S, Cunningham CH, Pauly JM, Kurhanewicz J, Vigneron DB. Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imaging. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 194: 121-7. PMID 18619875 DOI: 10.1016/J.Jmr.2008.06.010  0.395
2008 Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll PR, Zektzer AS, Kurhanewicz J. Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magnetic Resonance in Medicine. 60: 33-40. PMID 18581409 DOI: 10.1002/Mrm.21647  0.416
2008 Noworolski SM, Vigneron DB, Chen AP, Kurhanewicz J. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magnetic Resonance Imaging. 26: 1071-80. PMID 18508221 DOI: 10.1016/J.Mri.2008.01.033  0.469
2008 Chen AP, Kurhanewicz J, Bok R, Xu D, Joun D, Zhang V, Nelson SJ, Hurd RE, Vigneron DB. Feasibility of using hyperpolarized [1-13C]lactate as a substrate for in vivo metabolic 13C MRSI studies. Magnetic Resonance Imaging. 26: 721-6. PMID 18479878 DOI: 10.1016/J.Mri.2008.01.002  0.718
2008 Cabrera AR, Coakley FV, Westphalen AC, Lu Y, Zhao S, Shinohara K, Carroll PR, Kurhanewicz J. Prostate cancer: Is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology. 247: 444-450. PMID 18430877 DOI: 10.1148/Radiol.2472070770  0.48
2008 Cunningham CH, Chen AP, Lustig M, Hargreaves BA, Lupo J, Xu D, Kurhanewicz J, Hurd RE, Pauly JM, Nelson SJ, Vigneron DB. Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 193: 139-46. PMID 18424203 DOI: 10.1016/J.Jmr.2008.03.012  0.429
2008 Noworolski SM, Crane JC, Vigneron DB, Kurhanewicz J. A clinical comparison of rigid and inflatable endorectal-coil probes for MRI and 3D MR spectroscopic imaging (MRSI) of the prostate. Journal of Magnetic Resonance Imaging : Jmri. 27: 1077-82. PMID 18407539 DOI: 10.1002/Jmri.21331  0.388
2008 Hu S, Lustig M, Chen AP, Crane J, Kerr A, Kelley DA, Hurd R, Kurhanewicz J, Nelson SJ, Pauly JM, Vigneron DB. Compressed sensing for resolution enhancement of hyperpolarized 13C flyback 3D-MRSI. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 192: 258-64. PMID 18367420 DOI: 10.1016/J.Jmr.2008.03.003  0.384
2008 Westphalen AC, McKenna DA, Kurhanewicz J, Coakley FV. Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer Journal of Endourology. 22: 789-794. PMID 18366322 DOI: 10.1089/End.2007.9822  0.461
2008 Kurhanewicz J, Bok R, Nelson SJ, Vigneron DB. Current and potential applications of clinical 13C MR spectroscopy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 341-4. PMID 18322118 DOI: 10.2967/Jnumed.107.045112  0.507
2008 McKenna DA, Coakley FV, Westphalen AC, Zhao S, Lu Y, Webb EM, Pickett B, Roach M, Kurhanewicz J. Prostate cancer: Role of pretreatment MR in predicting outcome after external-beam radiation therapy - Initial experience Radiology. 247: 141-146. PMID 18258811 DOI: 10.1148/Radiol.2471061982  0.463
2008 Kurhanewicz J, Vigneron D, Carroll P, Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: Present and future Current Opinion in Urology. 18: 71-77. PMID 18090494 DOI: 10.1097/Mou.0B013E3282F19D01  0.513
2008 Kim Y, Hsu IC, Lessard E, Kurhanewicz J, Noworolski SM, Pouliot J. Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 88: 148-55. PMID 18083260 DOI: 10.1016/J.Radonc.2007.11.024  0.303
2008 Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, Zhao S, Carroll PR, Yeh BM, Kurhanewicz J. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology. 246: 177-84. PMID 18024434 DOI: 10.1148/Radiol.2453062042  0.487
2008 Kurhanewicz J. Magnetic Resonance Imaging Biomarkers of Prostate Cancer Aacr Education Book. 2008: 523-526. DOI: 10.1158/AACR.EDB-08-8146  0.367
2007 Chen AP, Albers MJ, Cunningham CH, Kohler SJ, Yen YF, Hurd RE, Tropp J, Bok R, Pauly JM, Nelson SJ, Kurhanewicz J, Vigneron DB. Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 58: 1099-106. PMID 17969006 DOI: 10.1002/Mrm.21256  0.517
2007 Rajesh A, Coakley FV, Kurhanewicz J. 3D MR spectroscopic imaging in the evaluation of prostate cancer Clinical Radiology. 62: 921-929. PMID 17765456 DOI: 10.1016/J.Crad.2007.04.014  0.474
2007 Kohler SJ, Yen Y, Wolber J, Chen AP, Albers MJ, Bok R, Zhang V, Tropp J, Nelson S, Vigneron DB, Kurhanewicz J, Hurd RE. In vivo 13 carbon metabolic imaging at 3T with hyperpolarized 13C-1-pyruvate. Magnetic Resonance in Medicine. 58: 65-9. PMID 17659629 DOI: 10.1002/Mrm.21253  0.727
2007 Testa C, Schiavina R, Lodi R, Salizzoni E, Corti B, Farsad M, Kurhanewicz J, Manferrari F, Brunocilla E, Tonon C, Monetti N, Castellucci P, Fanti S, Coe M, Grigioni WF, et al. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. Radiology. 244: 797-806. PMID 17652190 DOI: 10.1148/Radiol.2443061063  0.458
2007 Cunningham CH, Chen AP, Albers MJ, Kurhanewicz J, Hurd RE, Yen YF, Pauly JM, Nelson SJ, Vigneron DB. Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 187: 357-62. PMID 17562376 DOI: 10.1016/J.Jmr.2007.05.014  0.408
2007 Chen AP, Cunningham CH, Ozturk-Isik E, Xu D, Hurd RE, Kelley DA, Pauly JM, Kurhanewicz J, Nelson SJ, Vigneron DB. High-speed 3T MR spectroscopic imaging of prostate with flyback echo-planar encoding. Journal of Magnetic Resonance Imaging : Jmri. 25: 1288-92. PMID 17520729 DOI: 10.1002/Jmri.20916  0.454
2007 Costouros NG, Coakley FV, Westphalen AC, Qayyum A, Yeh BM, Joe BN, Kurhanewicz J. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: Role of endorectal MRI and MR spectroscopic imaging American Journal of Roentgenology. 188: 812-816. PMID 17312072 DOI: 10.2214/Ajr.06.0165  0.451
2007 Coakley FV, Chen I, Qayyum A, Westphalen AC, Carroll PR, Hricak H, Chen MH, Kurhanewicz J. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging. Bju International. 99: 41-5. PMID 17227490 DOI: 10.1111/J.1464-410X.2006.06515.X  0.464
2007 Hom JJ, Coakley FV, Simko JP, Lu Y, Qayyum A, Westphalen AC, Schmitt LD, Carroll PR, Kurhanewicz J. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience. Radiology. 242: 483-9. PMID 17179396 DOI: 10.1148/Radiol.2422051828  0.504
2007 Mueller-Lisse UG, Swanson MG, Vigneron DB, Kurhanewicz J. Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score. European Radiology. 17: 371-8. PMID 16791635 DOI: 10.1007/S00330-006-0321-3  0.432
2007 McKenna DA, Coakley FV, Westphalen AC, Zhao S, Lu Y, Webb EM, Pickett B, Roach M, Kurhanewicz J. 1785: Role of pre-treatment MR Imaging in the Prediction of Patient Outcome after External Beam Radiotherapy for Prostate Cancer The Journal of Urology. 177: 593-593. DOI: 10.1016/S0022-5347(18)31973-6  0.412
2006 Chen AP, Cunningham CH, Kurhanewicz J, Xu D, Hurd RE, Pauly JM, Carvajal L, Karpodinis K, Vigneron DB. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence. Magnetic Resonance Imaging. 24: 825-32. PMID 16916699 DOI: 10.1016/J.Mri.2006.03.002  0.426
2006 Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz J. Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magnetic Resonance in Medicine. 55: 1257-64. PMID 16685733 DOI: 10.1002/Mrm.20909  0.391
2006 Clifton MS, Joe BN, Zektzer AS, Kurhanewicz J, Vigneron DB, Coakley FV, Nobuhara KK, Swanson MG. Feasibility of magnetic resonance spectroscopy for evaluating fetal lung maturity. Journal of Pediatric Surgery. 41: 768-73. PMID 16567191 DOI: 10.1016/J.Jpedsurg.2006.02.020  0.325
2006 Alterovitz R, Goldberg K, Pouliot J, Hsu IC, Kim Y, Noworolski SM, Kurhanewicz J. Registration of MR prostate images with biomechanical modeling and nonlinear parameter estimation. Medical Physics. 33: 446-54. PMID 16532952 DOI: 10.1118/1.2163391  0.446
2006 Pickett B, Kurhanewicz J, Pouliot J, Weinberg V, Shinohara K, Coakley F, Roach M. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level. International Journal of Radiation Oncology, Biology, Physics. 65: 65-72. PMID 16517094 DOI: 10.1016/J.Ijrobp.2005.11.037  0.437
2006 Pels P, Ozturk-Isik E, Swanson MG, Vanhamme L, Kurhanewicz J, Nelson SJ, Van Huffel S. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis. Nmr in Biomedicine. 19: 188-97. PMID 16411280 DOI: 10.1002/Nbm.1008  0.362
2006 Hom JJ, Coakley FV, Simko JP, Qayyum A, Lu Y, Schmitt L, Carroll PR, Kurhanewicz J. Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions. Radiology. 238: 192-9. PMID 16373767 DOI: 10.1148/Radiol.2381041675  0.43
2006 Chung HT, Kurhanewicz J, Carroll PR, Roach M. 2272: A Pilot Study of Endorectal MRI and Spectroscopy Changes With Dutasteride in Patients With Low-Risk Prostate Cancer International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.679  0.415
2006 Pickett B, Kurhanewicz J, Speight J, Weinberg V, Shinohara K, Roach M. 132 : The Role of Endorectal Magnetic Resonance Spectroscopy Imaging (eMRSI) in the Management of Patients Treated With Salvage Brachytherapy for Locally Recurrent Prostate Cancer International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.163  0.45
2005 Kim Y, Hsu IC, Pouliot J, Noworolski SM, Vigneron DB, Kurhanewicz J. Expandable and rigid endorectal coils for prostate MRI: impact on prostate distortion and rigid image registration. Medical Physics. 32: 3569-78. PMID 16475755 DOI: 10.1118/1.2122467  0.47
2005 Prando A, Kurhanewicz J, Borges AP, Oliveira EM, Figueiredo E. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: Early experience Radiology. 236: 903-910. PMID 16118169 DOI: 10.1148/Radiol.2363040615  0.464
2005 Cunningham CH, Vigneron DB, Marjanska M, Chen AP, Xu D, Hurd RE, Kurhanewicz J, Garwood M, Pauly JM. Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T. Magnetic Resonance in Medicine. 53: 1033-9. PMID 15844147 DOI: 10.1002/Mrm.20478  0.46
2005 Keshari KR, Zektzer AS, Swanson MG, Majumdar S, Lotz JC, Kurhanewicz J. Characterization of intervertebral disc degeneration by high-resolution magic angle spinning (HR-MAS) spectroscopy. Magnetic Resonance in Medicine. 53: 519-27. PMID 15723415 DOI: 10.1002/Mrm.20392  0.321
2005 Zektzer AS, Swanson MG, Jarso S, Nelson SJ, Vigneron DB, Kurhanewicz J. Improved signal to noise in high-resolution magic angle spinning total correlation spectroscopy studies of prostate tissues using rotor-synchronized adiabatic pulses. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 53: 41-8. PMID 15690501 DOI: 10.1002/Mrm.20335  0.314
2005 Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI Magnetic Resonance in Medicine. 53: 249-255. PMID 15678552 DOI: 10.1016/S0022-5347(05)01052-9  0.427
2005 Vigneron D, Kurhanewicz J, Nelson S. WE-D-T-6C-04: MRI and MR Spectroscopic Imaging of Cancer Therapy Assessment Medical Physics. 32: 2136-2136. DOI: 10.1118/1.1998559  0.511
2005 Seo Y, Kurhanewicz J, Franc BL, Hawkins RA, Hasegawa BH. Improved prostate cancer imaging with SPECT/CT and MRI/MRSI Ieee Transactions On Nuclear Science. 52: 1316-1320. DOI: 10.1109/Tns.2005.858241  0.416
2005 Pickett B, Kurhanewicz J, Weinberg V, Pouliot J, Shinohara K, Roach M. Magnetic Resonance Spectroscopy Imaging and PSA Responses Following Three-Dimensional Conformal External Beam Radiotherapy (3DCRT) or 3DCRT plus Permanent Prostate Implant (PPI) for Intermediate Risk Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 63: S142. DOI: 10.1016/J.Ijrobp.2005.07.242  0.444
2005 Pickett B, Kurhanewicz J, Coakley F, Shinohara K, Fein B, Roach M, Zelefsky M. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer Urologic Oncology: Seminars and Original Investigations. 23: 310. DOI: 10.1016/J.Ijrobp.2004.05.015  0.444
2004 Alterovitz R, Goldberg K, Kurhanewicz J, Pouliot J, Hsu IC. Image registration for prostate MR spectroscopy using modeling and optimization of force and stiffness parameters. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 3: 1722-5. PMID 17272037 DOI: 10.1109/IEMBS.2004.1403517  0.374
2004 Pucar D, Koutcher JA, Shah A, Dyke JP, Schwartz L, Thaler H, Kurhanewicz J, Scardino PT, Kelly WK, Hricak H, Zakian KL. Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse. Clinical Prostate Cancer. 3: 174-81. PMID 15636684 DOI: 10.3816/Cgc.2004.N.028  0.471
2004 Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, Jones KD, Carroll PR, Kurhanewicz J. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology. 233: 701-8. PMID 15564406 DOI: 10.1148/Radiol.2333030672  0.489
2004 Pickett B, Kurhanewicz J, Coakley F, Shinohara K, Fein B, Roach M. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 60: 1047-55. PMID 15519774 DOI: 10.1016/j.ijrobp.2004.05.015  0.355
2004 Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L, Yeh BM, Carroll PR, Kurhanewicz J. Organ-confined prostate cancer: Effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging American Journal of Roentgenology. 183: 1079-1083. PMID 15385308 DOI: 10.2214/Ajr.183.4.1831079  0.461
2004 Coakley FV, Teh HS, Qayyum A, Swanson MG, Lu Y, Roach M, Pickett B, Shinohara K, Vigneron DB, Kurhanewicz J. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology. 233: 441-8. PMID 15375223 DOI: 10.1148/Radiol.2332032086  0.456
2004 Pouliot J, Kim Y, Lessard E, Hsu IC, Vigneron DB, Kurhanewicz J. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. International Journal of Radiation Oncology, Biology, Physics. 59: 1196-207. PMID 15234056 DOI: 10.1016/J.Ijrobp.2004.02.055  0.409
2004 Pickett B, Ten Haken RK, Kurhanewicz J, Qayyum A, Shinohara K, Fein B, Roach M. Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging International Journal of Radiation Oncology Biology Physics. 59: 665-673. PMID 15183469 DOI: 10.1016/J.Ijrobp.2003.11.024  0.451
2004 Dhingsa R, Qayyum A, Coakley FV, Lu Y, Jones KD, Swanson MG, Carroll PR, Hricak H, Kurhanewicz J. Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology. 230: 215-20. PMID 14695396 DOI: 10.1148/Radiol.2301021562  0.49
2004 Pickett B, Kurhanewicz J, Coakley F, Pouliot J, Albright N, Shinohara K, Roach M. Efficacy of external beam radiotherapy compared to permanent prostate implant in treating low risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and PSA International Journal of Radiation Oncology*Biology*Physics. 60: S185-S186. DOI: 10.1016/J.Ijrobp.2004.06.118  0.446
2003 Coakley FV, Qayyum A, Kurhanewicz J, Kantoff PW, Carroll PR, Roach M, Smith MR, Oh WK. Magnetic resonance imaging and spectroscopic imaging of prostate cancer Journal of Urology. 170: S69-S76. PMID 14610414 DOI: 10.1097/01.Ju.0000094958.23276.C4  0.488
2003 Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magnetic Resonance in Medicine. 50: 944-54. PMID 14587005 DOI: 10.1002/Mrm.10614  0.436
2003 Zhao YG, Xiao AZ, Newcomer RG, Park HI, Kang T, Chung LW, Swanson MG, Zhau HE, Kurhanewicz J, Sang QX. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. The Journal of Biological Chemistry. 278: 15056-64. PMID 12586837 DOI: 10.1074/Jbc.M210975200  0.306
2003 Pickett B, Kurhanewicz J, Fein B, Coakley F, Shinohara K, Roach M. Use of magnetic resonance imaging and spectroscopy in the evaluation of external beam radiation therapy for prostate cancer International Journal of Radiation Oncology Biology Physics. 57. DOI: 10.1016/S0360-3016(03)00943-X  0.431
2002 Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. Journal of Magnetic Resonance Imaging : Jmri. 16: 451-63. PMID 12353259 DOI: 10.1002/Jmri.10172  0.523
2002 Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, Carroll PR, Hricak H. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology. 223: 91-7. PMID 11930052 DOI: 10.1148/Radiol.2231010575  0.42
2002 Pickett B, Haken RKT, Kurhanewicz J, Wood P, Shinohara K, Roach M. Time course to metabolic atrophy following permanent prostate seed implantation based on magnetic resonance spectroscopic imaging International Journal of Radiation Oncology Biology Physics. 54: 31-32. DOI: 10.1016/S0360-3016(02)03110-3  0.444
2001 Roach M, Kurhanewicz J, Carroll P. Spectroscopy in prostate cancer: Hope or hype? Oncology. 15: 1399-1410. PMID 11758871  0.411
2001 Schricker AA, Pauly JM, Kurhanewicz J, Swanson MG, Vigneron DB. Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging Magnetic Resonance in Medicine. 46: 1079-1087. PMID 11746572 DOI: 10.1002/Mrm.1302  0.426
2001 Mueller-Lisse UG, Vigneron DB, Hricak H, Swanson MG, Carroll PR, Bessette A, Scheidler J, Srivastava A, Males RG, Cha I, Kurhanewicz J. Localized prostate cancer: Effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: Clinicopathologic case-controlled study Radiology. 221: 380-390. PMID 11687679 DOI: 10.1148/Radiol.2211001582  0.47
2001 Swanson MG, Vigneron DB, Tran TKC, Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer Cancer Investigation. 19: 510-523. PMID 11458818 DOI: 10.1081/Cnv-100103849  0.498
2001 Mueller-Lisse UG, Swanson MG, Vigneron DB, Hricak H, Bessette A, Males RG, Wood PJ, Noworolski S, Nelson SJ, Barken I, Carroll PR, Kurhanewicz J. Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 46: 49-57. PMID 11443710 DOI: 10.1002/Mrm.1159  0.441
2001 Swanson MG, Vigneron DB, Tran TKC, Sailasuta N, Hurd RE, Kurhanewicz J. Single-voxel oversampled J-Resolved spectroscopy of in vivo human prostate tissue Magnetic Resonance in Medicine. 45: 973-980. PMID 11378874 DOI: 10.1002/Mrm.1130  0.4
2001 Coakley FV, Hricak H, Wefer AE, Speight JL, Kurhanewicz J, Roach M. Brachytherapy for prostate cancer: endorectal MR imaging of local treatment-related changes. Radiology. 219: 817-821. PMID 11376276 DOI: 10.1148/Radiology.219.3.R01Jn46817  0.482
2001 Kurhanewicz J, Swanson MG, Wood PJ, Vigneron DB. Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials Urology. 57: 124-128. PMID 11295609 DOI: 10.1016/S0090-4295(00)00955-9  0.489
2001 Pickett B, Woods P, Kurhanewicz J, Shinohara K, Roach L. Quantification of magnetic resonance spectroscopic imaging for post permanent prostate seed implantation with 3 – 60 month follow-up International Journal of Radiation Oncology Biology Physics. 51: 198. DOI: 10.1016/S0360-3016(01)02184-8  0.411
2000 Kurhanewicz J, Vigneron DB, Nelson SJ. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia (New York, N.Y.). 2: 166-89. PMID 10933075 DOI: 10.1038/Sj.Neo.7900081  0.475
2000 Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J. Sextant localization of prostate cancer: Comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology Journal of Urology. 164: 400-404. PMID 10893595 DOI: 10.1016/S0022-5347(05)67370-3  0.488
2000 Kurhanewicz J, Vigneron DB, Males RG, Swanson MG, Yu KK, Hricak H. The prostate: MR imaging and spectroscopy. Present and future. Radiologic Clinics of North America. 38: 115-38, viii-ix. PMID 10664669 DOI: 10.1016/S0033-8389(05)70152-4  0.493
2000 Tran TK, Vigneron DB, Sailasuta N, Tropp J, Le Roux P, Kurhanewicz J, Nelson S, Hurd R. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magnetic Resonance in Medicine. 43: 23-33. PMID 10642728 DOI: 10.1002/(Sici)1522-2594(200001)43:1<23::Aid-Mrm4>3.0.Co;2-E  0.412
2000 Males RG, Vigneron DB, Star-Lack J, Falbo SC, Nelson SJ, Hricak H, Kurhanewicz J. Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 43: 17-22. PMID 10642727 DOI: 10.1002/(Sici)1522-2594(200001)43:1<17::Aid-Mrm3>3.0.Co;2-6  0.441
1999 Yu KK, Scheidler J, Hricak H, Vigneron DB, Zaloudek CJ, Males RG, Nelson SJ, Carroll PR, Kurhanewicz J. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology. 213: 481-8. PMID 10551230 DOI: 10.1148/Radiology.213.2.R99Nv26481  0.483
1999 Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. Radiology. 213: 473-80. PMID 10551229 DOI: 10.1148/radiology.213.2.r99nv23473  0.39
1999 Pickett B, Vigneault E, Kurhanewicz J, Verhey L, Roach M. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy International Journal of Radiation Oncology Biology Physics. 44: 921-929. PMID 10386651 DOI: 10.1016/S0360-3016(98)00502-1  0.4
1998 Parivar F, Kurhanewicz J. Detection of recurrent prostate cancer after cryosurgery. Current Opinion in Urology. 8: 83-86. PMID 17035847 DOI: 10.1097/00042307-199803000-00003  0.39
1998 Kaji Y, Kurhanewicz J, Hricak H, Sokolov DL, Huang LR, Nelson SJ, Vigneron DB. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology. 206: 785-90. PMID 9494502 DOI: 10.1148/Radiology.206.3.9494502  0.485
1998 Yu KK, Hricak H, Grossfeld GD, Kurhanewicz J, Segal MR, Carroll PR. Prediction of prostate cancer outcomes by MR spectroscopic imaging: Preliminary results Academic Radiology. 5: 756. DOI: 10.1016/S1076-6332(98)80690-9  0.44
1998 Pickett B, Vigneault E, Shinohara K, Kurhanewicz J, Hai J, Weaver K, Roach M. The use of endorectal magnetic resonance spectroscopy imaging (MRSI) to assess the efficacy of post implant dosimetry for permanent prostate implantation International Journal of Radiation Oncology Biology Physics. 42: 133. DOI: 10.1016/S0360-3016(98)80118-1  0.381
1997 Nelson SJ, Vigneron DB, Star-Lack J, Kurhanewicz J. High spatial resolution and speed in MRSI. Nmr in Biomedicine. 10: 411-22. PMID 9542738 DOI: 10.1002/(Sici)1099-1492(199712)10:8<411::Aid-Nbm496>3.0.Co;2-8  0.366
1997 Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 38: 311-21. PMID 9256113 DOI: 10.1002/Mrm.1910380222  0.33
1996 Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology. 48: 594-9. PMID 8886066 DOI: 10.1016/S0090-4295(96)00250-6  0.461
1996 Kurhanewicz J, Vigneron DB, Hricak H, Parivar F, Nelson SJ, Shinohara K, Carroll PR. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology. 200: 489-96. PMID 8685346 DOI: 10.1148/Radiology.200.2.8685346  0.496
1996 Kalbhen CL, Hricak H, Shinohara K, Chen M, Parivar F, Kurhanewicz J, Vigneron DB, Carroll PR. Prostate carcinoma: MR imaging findings after cryosurgery. Radiology. 198: 807-11. PMID 8628875 DOI: 10.1148/Radiology.198.3.8628875  0.476
1996 Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology. 198: 795-805. PMID 8628874 DOI: 10.1148/Radiology.198.3.8628874  0.472
1996 Chen M, Hricak H, Kalbhen CL, Kurhanewicz J, Vigneron DB, Weiss JM, Carroll PR. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. Ajr. American Journal of Roentgenology. 166: 1157-63. PMID 8615261 DOI: 10.2214/Ajr.166.5.8615261  0.456
1995 White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, Weiss JM, Narayan P, Carroll PR. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology. 195: 385-90. PMID 7724756 DOI: 10.1148/Radiology.195.2.7724756  0.476
1995 Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology. 45: 459-66. PMID 7533458 DOI: 10.1016/S0090-4295(99)80016-8  0.399
1994 Kurhanewicz J, Char DH, Stauffer P, Quivey JM, James TL. p magnetic resonance spectroscopy after combined hyperthermia and radiation Current Eye Research. 13: 151-156. PMID 8194362 DOI: 10.3109/02713689409042410  0.3
1994 Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P, Carroll PR. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. Radiology. 193: 703-9. PMID 7972810 DOI: 10.1148/Radiology.193.3.7972810  0.391
1993 Macdonald JM, Kurhanewicz J, Dahiya R, Espanol MT, Chang LH, Goldberg B, James TL, Narayan P. Effect of glucose and confluency on phosphorus metabolites of perfused human prostatic adenocarcinoma cells as determined by 31P MRS. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 29: 244-8. PMID 8429789 DOI: 10.1002/Mrm.1910290213  0.335
1993 Kurhanewicz J, Dahiya R, Macdonald JM, Chang LH, James TL, Narayan P. Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 29: 149-57. PMID 8429778 DOI: 10.1002/Mrm.1910290202  0.427
1992 Kurhanewicz J, Dahiya R, Macdonald JM, Jajodia P, Chang LH, James TL, Narayan P. Phosphorus metabolite characterization of human prostatic adenocarcinoma in a nude mouse model by 31P magnetic resonance spectroscopy and high pressure liquid chromatography. Nmr in Biomedicine. 5: 185-92. PMID 1449954 DOI: 10.1002/Nbm.1940050405  0.398
1992 Narayan P, Kurhanewicz J. Magnetic resonance spectroscopy in prostate disease : diagnostic possibilities and future developments The Prostate. 21: 43-50. PMID 1374177 DOI: 10.1002/Pros.2990210507  0.508
1992 Thomas M, Narayan P, Kurhanewicz J, Jajodia P, James T, Weiner M. Detection of phosphorus metabolites in human prostates with a transrectal31P NMR probe Journal of Magnetic Resonance (1969). 99: 377-386. DOI: 10.1016/0022-2364(92)90190-I  0.392
1991 Kurhanewicz J, Thomas A, Jajodia P, Weiner MW, James TL, Vigneron DB, Narayan P. 31P spectroscopy of the human prostate gland in vivo using a transrectal probe. Magnetic Resonance in Medicine. 22: 404-13. PMID 1725918 DOI: 10.1002/Mrm.1910220248  0.428
1991 Narayan P, Jajodia P, Kurhanewicz J, Thomas A, MacDonald J, Hubesch B, Hedgcock M, Anderson CM, James TL, Tanagho EA, Weiner M. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: A preliminary report Journal of Urology. 146: 66-74. PMID 1711587 DOI: 10.1016/S0022-5347(17)37716-9  0.427
1990 Kucharczyk J, Moseley M, Kurhanewicz J, Norman D. MRS of ischemic/hypoxic brain disease. Investigative Radiology. 24: 951-4. PMID 2691441 DOI: 10.1097/00004424-198912000-00005  0.381
1990 Thomas M, Narayan P, Kurhanewicz J, Jajodia P, Weiner M. 1H MR spectroscopy of normal and malignant human prostates in Vivo Journal of Magnetic Resonance (1969). 87: 610-619. DOI: 10.1016/0022-2364(90)90319-5  0.406
Show low-probability matches.